本页面由Tiger Trade Technology Pte. Ltd.提供服务

Compugen医疗

1.98
-0.0900-4.35%
盘后:2.010.0300+1.52%19:30 EDT
成交量:22.36万
成交额:45.36万
市值:1.87亿
市盈率:5.30
高:2.09
开:2.09
低:1.96
收:2.07
52周最高:3.24
52周最低:1.43
股本:9,455.41万
流通股本:9,245.75万
量比:1.22
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):0.3733
每股收益(LYR):0.3783
净资产收益率:50.64%
总资产收益率:15.46%
市净率:2.11
市盈率(LYR):5.23

数据加载中...

2020/03/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/24

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/20

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/06

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/08

SEC问询函

[Cover]Correspondence